Table 1. OVs used in PNST pre-clinical models.
Abbreviations: GFP, enhanced green fluorescent protein; h, human; IL, interleukin; LacZ, β-galactosidase; NIS, sodium/iodide symporter; pro, promoter; TIMP3, tissue inhibitor of metalloproteinases 3; IE4/5, immediate-early gene 4/5.
Oncolytic Virus | Genetic Modifications | Transgene | Drug Combination | PNST Model | Ref. |
---|---|---|---|---|---|
oHSV | |||||
G47Δ | γ34.5Δ, ICP6-, ICP47Δ, LacZ+ | MPNST orthotopic sciatic nerve, Transgenic schwannoma, Subcutaneous schwannoma | 49, 50, 57, 65 | ||
G207 | γ34.5Δ, ICP6- | Subcutaneous and intraperitoneal human MPNST in athymic mice | 52, 54 | ||
NV1023 | UL56Δ/1 copy of ICP0, ICP4 and γ34.5 | Perineural invasion model in sciatic nerve | 60, 61 | ||
G207 | γ34.5Δ, ICP6- | Erlotinib | Subcutaneous and intraperitoneal: human MPNST in athymic mice | 54 | |
rQT3 | γ34.5Δ, ICP6- | IE4/5pro-TIMP3, ICP6-GFP fusion in ICP6 | MPNST xenograft models | 55 | |
hrR3 | ICP6-, LacZ+ | Subcutaneous and intraperitoneal human MPNST in athymic mice | 54 | ||
oHSV-MDK-34.5 | Mdk pro-γ34.5 and ICP6-GFP fusion in ICP6 | Subcutaneous human MPNST in athymic mice | 56 | ||
G47Δ-PF4 | γ34.5Δ, ICP6-, ICP47Δ, ICP47pro-Us11 | PF4 | Subcutaneous MPNST xenograft, MPNST orthotopic sciatic nerve in immunocompetent mice | 57 | |
G47Δ-dnFGFR | γ34.5Δ, ICP6-, ICP47Δ, ICP47pro-Us11 | dnFGFR | Subcutaneous MPNST xenograft, MPNST orthotopic sciatic nerve in immunocompetent mice | 64 | |
G47Δ-mIL12 | γ34.5Δ, ICP6Δ | mIL-12 | MPNST orthotopic sciatic nerve in immunocompetent mice | 65 | |
Other OVs | |||||
Ad5/3-D24-GMCSF | Ad5/3 fiber, E1A 24-bpΔ, E3Δ | hGMCSF | doxorubicin, ifosfamide | leiomyosarcoma cells in Syrian hamster | 74 |
MV-NIS | Edmonston vaccine strain | NIS | Subcutaneous human MPNST in athymic mice | 77 | |
VSV-rp30a | Disruption of gene order | In vitro human MPNST cell lines | 81 |